Merck (MRK) Reports Positive Top-line Results from Pivotal Phase 3 STELLAR Trial of Sotatercept

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. ABBV
2. ACN
3. IBM
4. MU
5. PRIM
6. DPZ
7. NAVN
8. NVDA
9. DFTX
10. META

Go back to Merck (MRK) Reports Positive Top-line Results from Pivotal Phase 3 STELLAR Trial of Sotatercept
Merck & Co. (NYSE: MRK) Delayed: 115.48 --0 (-0%)
Previous Close $115.48    52 Week High $65.46 
Open $115.48    52 Week Low $47.97 
Day High $115.48    P/E 78.56 
Day Low $115.48    EPS $1.47 
Volume 20,283